EXHIBIT 2.1.3
LIMITED LIABILITY COMPANY
AGREEMENT
OF
PERSEID THERAPEUTICS
LLC
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE 1. DEFINED TERMS
|
|
1
|
|
|
|
|
Section 1.02
|
|
Interpretation
|
|
9
|
|
|
|
ARTICLE 2. GENERAL MATTERS
|
|
9
|
|
|
|
|
Section 2.01
|
|
Formation
|
|
9
|
|
Section 2.02
|
|
Name
|
|
10
|
|
Section 2.03
|
|
Term
|
|
10
|
|
Section 2.04
|
|
Registered Agent and Registered
Office
|
|
10
|
|
Section 2.05
|
|
Principal Place of Business
|
|
10
|
|
Section 2.06
|
|
Purposes and Powers
|
|
10
|
|
Section 2.07
|
|
Books and Records
|
|
10
|
|
|
|
ARTICLE 3. MEMBERS
|
|
11
|
|
|
|
|
Section 3.01
|
|
Members
|
|
11
|
|
Section 3.02
|
|
Powers of Members
|
|
11
|
|
Section 3.03
|
|
Voting Rights
|
|
11
|
|
Section 3.04
|
|
Meetings and Written Consents of
Members
|
|
12
|
|
Section 3.05
|
|
Liability of Members, Managers, Etc.
|
|
13
|
|
Section 3.06
|
|
Resignation
|
|
17
|
|
|
|
ARTICLE 4. NEW ISSUANCES; UNITS;
CONVERSION
|
|
17
|
|
|
|
|
Section 4.01
|
|
New Issuances of Equity Capital
|
|
17
|
|
Section 4.02
|
|
Units
|
|
18
|
|
Section 4.03
|
|
Conversion
|
|
19
|
|
|
|
ARTICLE 5. GOVERNANCE
|
|
27
|
|
|
|
|
Section 5.01
|
|
Board of Managers
|
|
27
|
|
Section 5.02
|
|
Meetings and Written Consents of Board of
Managers
|
|
28
|
|
Section 5.03
|
|
Committees
|
|
28
|
|
Section 5.04
|
|
Officers
|
|
29
|
|
Section 5.05
|
|
Series A Preferred Unit Protective
Provisions
|
|
29
|
|
Section 5.06
|
|
Series B Preferred Unit Protective
Provisions
|
|
32
|
|
|
|
ARTICLE 6. CAPITAL ACCOUNTS
|
|
34
|
|
|
|
|
Section 6.01
|
|
Capital Contributions
|
|
34
|
|
Section 6.02
|
|
Interest on Capital
|
|
35
|
|
Section 6.03
|
|
Limitation of Liability; Return or Withholding
of Certain Distributions
|
|
35
|
|
|
|
ARTICLE 7. PROFITS AND LOSSES
|
|
35
|
|
|
|
|
Section 7.01
|
|
Allocations of Profits and Losses of the
Company
|
|
35
|
|
Section 7.02
|
|
Allocation Adjustments to Comply with
Section 704(b) of the Code
|
|
36
|
-i-
TABLE OF CONTENTS
(Continued)
|
|
|
|
|
|
|
|
|
|
Page
|
|
Section 7.03
|
|
General Provisions Regarding Allocations and
Capital Account Maintenance
|
|
37
|
|
Section 7.04
|
|
Nonallocation of Distributions to Increases in
Minimum Gain
|
|
38
|
|
Section 7.05
|
|
Allocation of Liabilities
|
|
38
|
|
Section 7.06
|
|
Modifications to Preserve Underlying Economic
Objectives
|
|
39
|
|
Section 7.07
|
|
Withholding Taxes
|
|
39
|
|
Section 7.08
|
|
Intent of Allocations
|
|
39
|
|
|
|
ARTICLE 8. DISTRIBUTIONS; ASSETS
SALES
|
|
40
|
|
|
|
|
Section 8.01
|
|
Distributions
|
|
40
|
|
Section 8.02
|
|
Liquidity Event Distributions
|
|
40
|
|
|
|
ARTICLE 9. DISSOLUTION; TAX MATTERS;
CONVERSION TO CORPORATION
|
|
41
|
|
|
|
|
Section 9.01
|
|
Dissolution
|
|
41
|
|
Section 9.02
|
|
Liquidation
|
|
42
|
|
Section 9.03
|
|
Tax Matters
|
|
42
|
|
Section 9.04
|
|
Conversion to a Corporation
|
|
43
|
|
|
|
ARTICLE 10. MISCELLANEOUS
|
|
44
|
|
|
|
|
Section 10.01
|
|
Notices
|
|
44
|
|
Section 10.02
|
|
Delays or Omissions
|
|
46
|
|
Section 10.03
|
|
Successors and Assigns
|
|
46
|
|
Section 10.04
|
|
Severability
|
|
47
|
|
Section 10.05
|
|
Counterparts
|
|
47
|
|
Section 10.06
|
|
Entire Agreement
|
|
47
|
|
Section 10.07
|
|
Governing Law
|
|
47
|
|
Section 10.08
|
|
Jurisdiction; Venue
|
|
47
|
|
Section 10.09
|
|
Amendments
|
|
47
|
|
Section 10.10
|
|
Construction
|
|
48
|
-ii-
This LIMITED LIABILITY COMPANY
AGREEMENT (this “ Agreement ”) of Perseid
Therapeutics LLC, a Delaware limited liability company (the “
Company ”), is dated as of September 18, 2009, by
and between Maxygen, Inc., a Delaware corporation (“
Maxygen ”) and Astellas Bio Inc., a Delaware
corporation (“ Bio ”).
WHEREAS, the Company has been formed
as a limited liability company under the Delaware Limited Liability
Company Act (6 Del. C. § 18 101, et seq.), as
amended from time to time (the “ Delaware Act
”), pursuant to the Certificate of Formation, as filed in the
office of the Secretary of State of the State of Delaware;
and
WHEREAS, the Initial Members desire
to enter into this Agreement to set forth certain agreements
relating to the ownership, management and operation of the
Company.
NOW, THEREFORE, in consideration of
the agreements and obligations set forth herein and for other good
and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Members hereby agree as
follows:
ARTICLE 1.
DEFINED TERMS
Unless the context otherwise
requires, the terms defined in this Article 1 shall, for the
purposes of this Agreement, have the meanings herein specified. All
capitalized terms used and not defined herein shall have the
meanings set forth in that certain Master Joint Venture Agreement
(the “ Joint Venture Agreement ”) dated as of
June 30, 2009 by and among Maxygen, Bio and Astellas Pharma
Inc., a Japanese corporation.
“ Additional Common
Units ” shall have the meaning set forth in
Section 4.03(d)(i).
“ Additional Member
” shall have the meaning set forth in
Section 3.01(b).
“ Adjusted Capital Account
Deficit ” shall mean, with respect to any Member, the
deficit balance, if any, in such Member’s Capital Account as
of the end of the relevant Fiscal Year, after giving effect to the
following adjustments:
(a) the Capital Account shall be
increased by any amounts that such Member is obligated to restore
pursuant to any provision of this Agreement or is deemed to be
obligated to restore pursuant to the penultimate sentence of each
of Treasury Regulations Sections 1.704-2(g)(1) and 1.704-2(i)(5);
and
(b) the Capital Account shall be
decreased by the items described in Treasury Regulations Sections
1.704-1(b)(2)(ii)(d)(4), 1.704-1(b)(2)(ii)(d)(5) and
1.704-1(b)(2)(ii)(d)(6).
The foregoing definition of Adjusted Capital
Account Deficit is intended to comply with the provisions of
Treasury Regulations Section 1.704-1(b)(2)(ii)(d) and shall be
interpreted consistently therewith.
“ Adoption Agreement
” shall mean an agreement confirming the agreement of a
Person to be bound by the terms and provisions of this
Agreement.
“ Agreement ”
shall have the meaning set forth in the preamble hereof.
“ Annual Distribution
Rate ” shall mean an annual rate of $0.08 per Series A
Preferred Unit and $0.08 per Series B Preferred Unit (in each case
subject to adjustment from time to time for Recapitalizations as
set forth elsewhere herein).
“ Automatic Conversion
Event ” shall have the meaning set forth in
Section 4.03(b).
“ Bio ” shall
have the meaning set forth in the preamble hereof.
“ Bio Manager ”
shall have the meaning set forth in
Section 4.03(d)(i)(2).
“ Board of Managers
” shall have the meaning set forth in
Section 5.01(a).
“ Buy-Out Units ”
has the meaning defined in the Investors’ Rights
Agreement.
“ Capital Account
” shall mean, for each Member, a separate account that
is:
(a) increased by: (i) the
amount of such Member’s Capital Contribution and
(ii) allocations of Profits and other items in the nature of
income and gain to such Member pursuant to
Article 7;
(b) decreased by: (i) the
amount of cash distributed to such Member by the Company;
(ii) the fair market value as of the time of Distribution, and
net of liabilities secured by such property that the Member assumes
or to which the Member’s ownership of the property is
subject, of any other property distributed to such Member by the
Company; and (iii) allocations of Losses and other items in
the nature of expenses or losses to such Member pursuant to
Article 7;
(c) otherwise adjusted in accordance
with the provisions of this Agreement; and
(d) revalued in connection with any
event described in paragraph (a) of the definition of
“Gross Asset Value” to the extent it is determined in
the discretion of the Managing Member in consultation with Bio
prior to the Option Expiration Date that a revaluation is necessary
to preserve the economic arrangement of the Members. In determining
the amount of any liability for purposes of subparagraphs (a)
and (b) above, there shall be taken into account
Section 752(c) of the Code and any other applicable provisions
of the Code and Treasury Regulations.
Capital Accounts shall be maintained
in accordance with Treasury Regulations Section 1.704-1(b) and
specifically in a manner consistent with the Member’s
interest in the Company, and the provisions of this Agreement shall
be interpreted and applied in a manner consistent with such
regulations and intent.
-2-
“ Capital Contribution
” shall mean, for any Member, the sum of the net amount of
cash and the fair market value as of the time of contribution, and
net of liabilities secured by such property that the Company
assumes or to which the Company’s ownership of the property
is subject, of any other property contributed by such Member to the
capital of the Company. For purposes of this Agreement, each
Capital Contribution shall be deemed to have been made at the later
of: (a) the Close of Business on the due date of such Capital
Contribution as determined in accordance with this Agreement; or
(b) the Close of Business on the date on which such Capital
Contribution is actually received by the Company.
“ Certificate of
Formation ” shall mean the Certificate of Formation of
the Company and any and all amendments thereto and restatements
thereof filed on behalf of the Company with the office of the
Secretary of State of the State of Delaware pursuant to the
Delaware Act.
“ Company ” shall
have the meaning set forth in the preamble hereof.
“ Conversion Price
” shall mean $1.00 per Series A Preferred Unit and $1.00
per Series B Preferred Unit (in each case subject to adjustment
from time to time for Recapitalizations and as otherwise set forth
elsewhere herein).
“ Conversion Rate
” shall have the meaning set forth in
Section 4.03(a).
“ Convertible
Securities ” shall mean any evidences of indebtedness,
shares, membership units, or other securities convertible into or
exchangeable for Common Units (as such term is defined in the
Voting Agreement).
“ Delaware Act ”
shall have the meaning set forth in the preamble hereof.
“ Depreciation ”
means, for each Fiscal Year or other period, an amount equal to the
depreciation, amortization or other cost recovery deduction
allowable with respect to an asset for such Fiscal Year or other
period; provided , however , that if the Gross Asset
Value of an asset differs from its adjusted basis for U.S. federal
income tax purposes at the beginning of such Fiscal Year or other
period, Depreciation shall be an amount that bears the same ratio
to such beginning Gross Asset Value as the U.S. federal income tax
depreciation, amortization or other cost recovery deduction with
respect to such asset for such Fiscal Year or other period bears to
such beginning adjusted tax basis; and provided
further , that if the U.S. federal income tax depreciation,
amortization or other cost recovery deduction for such Fiscal Year
or other period is zero, Depreciation shall be determined with
reference to such beginning Gross Asset Value using any reasonable
method selected by the Managing Member and in consultation with Bio
prior to the Option Expiration Date.
-3-
“ Distribution ”
shall mean the transfer of cash or other property without
consideration whether by way of dividend or otherwise (other than
dividends on Common Units payable in Common Units), or the purchase
or redemption of Units by the Company for cash or
property.
“ Distribution
Threshold ” shall have the meaning set forth in
Section 4.02(c).
“ Equity Incentive Plan
” shall mean the Company 2009 Equity Incentive Plan under
which Common Units shall be reserved for current or future grant
for issuance to Managers, officers, employees, and other service
providers as provided therein.
“ Exchange Act ”
shall mean the Securities Exchange Act of 1934, as
amended.
“ Excluded Opportunity
” shall mean any matter, transaction or interest that is
presented to, or acquired, created or developed by, or which
otherwise comes into the possession of, (i) any Manager of the
Company who is not an employee of the Company or any of its
Subsidiaries, or (ii) any Member holding Preferred Units or
any Affiliate, partner, member, director, stockholder, employee,
agent or other related person of any such Member, other than
someone who is an employee of the Company or any of its
Subsidiaries (collectively, “ Excluded Opportunity
Persons ”), unless such matter, transaction or interest
is presented to, or acquired, created or developed by, or otherwise
comes into the possession of, an Excluded Opportunity Person
expressly in such Excluded Opportunity Person’s capacity as a
Manager of the Company.
“ Exercise Price
” has the meaning defined in the Investors’ Rights
Agreement.
“ Fair Market Value
” shall mean, as of any date prior to the expiration of the
Buy-Out Option, the value of Profits Interest Units derived from
the deemed value of the Company in light of the applicable Exercise
Price for the Buy-Out Units, the applicable Distribution Threshold
for the Profits Interest Units, the then fully-diluted
capitalization of the Company, and the then liquidation
preferences, participation rights and other terms and conditions of
the Company’s Units and, as of the expiration of the Buy-Out
Option and any date following such expiration, the fair market
value of the Profits Interest Units determined in good faith by the
Administrator (as defined in the Company’s 2009 Equity
Incentive Plan).
“ Fiscal Period ”
shall mean the Fiscal Year or such shorter period as necessary to
take into account the Members’ varying interests in the
Company.
“ Fiscal Year ”
shall mean the fiscal year of the Company, initially the period
commencing on January 1 in any calendar year and ending on
December 31 in that calendar year, except as otherwise
required by law, including the Code or Treasury
Regulations.
“ Gross Asset Value
” shall mean, with respect to any asset, such asset’s
adjusted basis for U.S. federal income tax purposes, except as
follows:
(a) the Gross Asset Value of all
Company assets shall be adjusted to equal their respective fair
market values, taking Section 7701(g) of the Code into
account, immediately prior to
-4-
the following times: (i) the acquisition of
an additional interest in the Company by any new or existing Member
in exchange for more than a de minimis Capital Contribution;
(ii) the distribution by the Company to a Member of more than
a de minimis amount of Company assets as consideration for
an interest in the Company; (iii) the grant of an interest in
the Company (other than a de minimis interest) as
consideration for the provision of services to or for the benefit
of the Company by an existing Member acting in a Member capacity,
or by a new Member acting in a Member capacity or in anticipation
of becoming a Member; and (iv) the liquidation of the Company
within the meaning of Treasury Regulations
Section 1.704-1(b)(2)(ii)(g); provided , however
, that adjustments pursuant to clause (i), (ii) and
(iii) of this sentence shall be made only if it reasonably
determined by the Managing Member in consultation with Bio prior to
the Option Expiration Date that such adjustments are necessary or
appropriate to reflect the relative economic interests of the
Members in the Company; and
(b) the Gross Asset Value of any
Company asset distributed to any Member shall be adjusted to equal
the fair market value, taking Section 7701(g) of the Code into
account, of such asset on the date of Distribution.
If the Gross Asset Value of an asset
has been determined or adjusted pursuant to paragraph (a) or
paragraph (b) above, such Gross Asset Value shall thereafter
be adjusted by the Depreciation taken into account with respect to
such asset for purposes of computing Profits and Losses.
“ Initial Members
” shall mean Maxygen and Bio.
“ Lender ” shall
have the meaning set forth in the Bridge Loan Agreement.
“ Liquidity Event
” shall be deemed to be occasioned by, or to include,
(a) the acquisition of the Company by another entity by means
of any transaction or series of related transactions to which the
Company is party (including, without limitation, any acquisition of
Units reorganization, merger or consolidation but excluding any
sale of Units solely for capital raising purposes) other than
(i) a transaction or series of related transactions in which
the holders of the voting securities of the Company outstanding
immediately prior to such transaction or series of related
transactions retain, immediately after such transaction or series
of related transactions, as a result of Units held by such holders
prior to such transaction or series of related transactions, at
least a majority of the total voting power represented by the
outstanding voting securities of the Company or such other
surviving or resulting entity (or if the Company or such other
surviving or resulting entity is a wholly-owned Subsidiary
immediately following such acquisition, its parent) or
(ii) the consummation of the purchase of Units pursuant to the
Buy-Out Option, as such term is defined in the Investors’
Rights Agreement; (b) a sale, lease or other disposition of
all or substantially all of the assets of the Company and its
subsidiaries taken as a whole by means of any transaction or series
of related transactions, except where such sale, lease or other
disposition is to a wholly-owned Subsidiary of the Company; or
(c) any liquidation, dissolution or winding up of the Company,
whether voluntary or involuntary.
-5-
“ Liquidation
Preference ” shall mean $1.00 per Series A Preferred Unit
and $1.00 per Series B Preferred Unit (in each case subject to
adjustment from time to time for Recapitalizations as set forth
elsewhere herein).
“ Liquidation Rights
” shall have the meaning set forth in
Section 4.03(g).
“ Loan ” shall
have the meaning set forth in the Bridge Loan Agreement.
“ Manager ” shall
have the meaning set forth in Section 5.01(b).
“ Managing Member
” shall mean Maxygen, or its successor or assign.
“ Maxygen ” shall
have the meaning set forth in the preamble hereof.
“ Maxygen Manager
” shall have the meaning set forth in
Section 4.03(d)(i)(2).
“ Member ” shall
mean any of the Initial Members and any Additional Member until
such Person ceases to be a Member of the Company in accordance with
the terms of this Agreement.
“ Member Minimum Gain
” means an amount, with respect to each Member Nonrecourse
Debt, equal to the Company Minimum Gain that would result if such
Member Nonrecourse Debt were treated as a nonrecourse liability,
determined in accordance with Treasury Regulations
Section 1.704-2(i)(3).
“ Member Nonrecourse
Debt ” has the same meaning as the term “partner
nonrecourse debt” in Treasury Regulations
Section 1.704-2(b)(4).
“ Member Nonrecourse
Deduction ” shall mean an item of loss, expense or
deduction attributable to a nonrecourse liability of the Company
for which a Member bears the economic risk of loss within the
meaning of Treasury Regulations Section 1.704-2(i).
“ Minimum Gain ”
of the Company or “ Company Minimum Gain ”
shall, as provided in Treasury Regulations Section 1.704-2,
mean the total amount of gain the Company would realize for federal
income tax purposes if it disposed of all assets subject to
nonrecourse liability for no consideration other than full
satisfaction thereof.
“ Option Expiration
Date ” shall have the meaning set forth in the
Investors’ Rights Agreement.
“ Options ” shall
mean rights, options or warrants to subscribe for, purchase or
otherwise acquire Common Units or Convertible
Securities.
“ Original Issue Price
” shall mean $1.00 per Series A Preferred Unit and $1.00
per Series B Preferred Unit (in each case subject to adjustment
from time to time for Recapitalizations as set forth elsewhere
herein).
-6-
“ Percentage Interest
” of any Member shall mean the product of (x) the
quotient of the number of Common Units held by such Member (with
the Preferred Units held by such Member being treated for this
purpose as if they had been converted to Common Units at the then
applicable Conversion Rate) divided by the total number of
outstanding Units multiplied by (y) 100.
“ Permitted Equity
Offering ” shall mean any offering of Units, securities
linked to Units or any other equity security (including any
security convertible into or exercisable for any equity security)
of the Company that (a) are offered and sold to Maxygen or its
Affiliates, (b) are offered and sold to any Person other than
Maxygen or its Affiliates, provided that Maxygen and its
Affiliates hold a majority of the outstanding Units immediately
following such offering and sale or (c) are junior to the
Series B Preferred Units.
“ Permitted
Indebtedness ” shall mean (a) accounts payable to
trade creditors for goods and services and current operating
liabilities (not the result of the borrowing of money) incurred in
the ordinary course of the Company’s or such
Subsidiary’s business in accordance with customary terms and
paid within the specified time, unless contested in good faith by
appropriate proceedings and reserved for in accordance with GAAP;
(b) indebtedness consisting of guarantees resulting from
endorsement of negotiable instruments for collection by the Company
or any such Subsidiary in the ordinary course of business;
(c) interest rate swaps, currency swaps and similar financial
products entered into or obtained in the ordinary course of
business; (d) capital leases or other indebtedness incurred
solely to acquire and secure the purchase price of equipment,
computers, software or implement tenant improvements and is not in
excess of the lesser of the purchase price or the fair market value
of such equipment, computers, software or tenant improvements on
the date of acquisition; and (e) unsecured indebtedness of the
Company to any of its wholly owned Subsidiaries or of any of its
wholly owned Subsidiaries to another of its wholly owned
Subsidiaries that is not senior to any indebtedness outstanding
under the Bridge Loan Agreement.
“ Person ” shall
mean any individual, corporation, association, partnership (general
or limited), joint venture, trust, estate, limited liability
company or other legal entity or organization.
“ Profits Interest Unit
” shall have the meaning set forth in
Section 4.02(c).
“ Profits and Losses
” shall mean, for each Fiscal Year or other Fiscal Period, an
amount equal to the Company’s taxable income or loss for such
Fiscal Year or other Fiscal Period, as applicable, determined in
accordance with Section 703(a) of the Code (but including in
taxable income or loss, for this purpose, all items of income,
gain, loss or deduction required to be stated separately pursuant
to Section 703(a)(1) of the Code), with the following
adjustments:
(a) any income of the Company exempt
from U.S. federal income tax and not otherwise taken into account
in computing Profits or Losses pursuant to this definition shall be
added to such taxable income or loss;
(b) any expenditures of the Company
described in Section 705(a)(2)(B) of the Code (or treated as
expenditures described in Section 705(a)(2)(B) of the Code
pursuant to Treasury Regulations Section 1.704-1(b)(2)(iv)(i))
and not otherwise taken into account in computing Profits or Losses
pursuant to this definition shall be subtracted from such taxable
income or loss;
-7-
(c) in the event that the Gross
Asset Value of any Company asset is adjusted in accordance with
paragraphs (a) or (b) of the definition of “Gross
Asset Value,” the amount of such adjustment shall be taken
into account as gain or loss from the disposition of such asset for
purposes of computing Profits or Losses;
(d) gain or loss resulting from any
disposition of any asset of the Company with respect to which gain
or loss is recognized for U.S. federal income tax purposes shall be
computed by reference to the Gross Asset Value of the asset
disposed of, notwithstanding that the adjusted tax basis of such
asset differs from its Gross Asset Value;
(e) in lieu of the depreciation,
amortization and other cost recovery deductions taken into account
in computing such taxable income or loss, there shall be taken into
account Depreciation for such Fiscal Year or other Fiscal Period,
computed in accordance with the definition of
“Depreciation” above; and
(f) to the extent an adjustment to
the adjusted tax basis of any Company asset pursuant to Code
Section 734(b) or Code Section 743(b) is required
pursuant to Treasury Regulations Section 1.704
1(b)(2)(iv)(m)(4) to be taken into account in determining Capital
Accounts as a result of a distribution other than in complete
liquidation of a Member’s interest, the amount of such
adjustment shall be treated as an item of gain (if the adjustment
increases the basis of the asset) or loss (if the adjustment
decreases the basis of the asset) from the disposition of the asset
and shall be taken into account for purposes of computing Profits
and Losses; and
(g) notwithstanding any other
provision of this definition, any items which are specially
allocated pursuant to Section 7.02(b) through
Section 7.02(g) shall not be taken into account in computing
Profits or Losses, but the amount thereof shall be determined under
principles analogous to those set forth in clauses (a) through
(f) of this definition.
“ Proposed Treasury
Regulation ” shall have the meaning set forth in
Section 4.02(d).
“ Qualified Public
Offering ” shall have the meaning set forth in
Section 4.03(b).
“ Recapitalization
” shall mean any Unit dividend, Unit split, combination of
Units, reorganization, recapitalization, reclassification or other
similar event.
“ Related Entity
” shall mean, with respect to any Member, (i) any
corporation, trust, limited liability company, association or other
entity in which such Member holds an 80% or greater equity
interest, (ii) any parent corporation, trust, limited
liability company or association, or other parent entity, of such
Member or (iii) any liquidating trust or similar entity
established for the benefit of such Member’s
equityholders.
“ Safe Harbor ”
shall have the meaning set forth in
Section 4.02(d).
-8-
“ Sarbanes-Oxley Act
” shall mean the Sarbanes-Oxley Act of 2002, as
amended.
“ Securities Act
” shall mean the United States Securities Act of 1933, as
amended.
“ Subsidiary ”
shall have the meaning set forth in the Bridge Loan
Agreement.
“ Treasury Regulations
” shall mean the regulations issued by the United States
Treasury Department and relating to a matter arising under the
Code.
“ Unit ” shall
mean a unit of limited liability company interest in the Company
and includes, without limitation, the Common Units and the
Preferred Units.
“ Updated Capital
Account ” shall mean, with respect to a Member, such
Member’s Capital Account determined as if, immediately prior
to the time of determination, all of the Company’s assets had
been sold for fair market value and any previously unallocated
Profits and Losses had been allocated pursuant to
Article 7.
SECTION 1.02
Interpretation . Unless otherwise indicated herein,
with respect to any reference made in this Agreement to a Section
(or Article, Subsection, Paragraph, Subparagraph or Clause),
Exhibit or Schedule, such reference shall be to a section (or
article, subsection, paragraph, subparagraph or clause) of, or an
exhibit or schedule to, this Agreement. The table of contents and
any article, section, subsection, paragraph or subparagraph
headings contained in this Agreement and the recitals at the
beginning of this Agreement are for reference purposes only and
shall not affect in any way the meaning or interpretation of this
Agreement. Whenever the words “include,”
“includes” or “including” are used in this
Agreement, they shall be deemed, as the context indicates, to be
followed by the words “but (is/are) not limited to.”
Words used herein, regardless of the number and gender specifically
used, shall be deemed and construed to include any other number,
singular or plural, and any other gender, masculine, feminine or
neuter, as the context indicates is appropriate. Where specific
language is used to clarify or illustrate by example a general
statement contained herein, such specific language shall not be
deemed to modify, limit or restrict the construction of the general
statement which is being clarified or illustrated. Unless otherwise
specified, any reference to a time or date shall be with reference
to the time or date, as the case may be, in Wilmington,
Delaware.
ARTICLE 2.
GENERAL MATTERS
SECTION 2.01 Formation
.
(a) Pursuant to the provisions of
the Delaware Act, the Company was formed on September 8, 2009,
by the filing in the Office of the Secretary of State of the State
of Delaware of a Certificate of Formation (which filing is hereby
approved and ratified in all respects). The sole organizer of the
Company is hereby designated as an “authorized person,”
within the meaning of Section 18-201 of the Delaware Act, and
all acts of such sole organizer in forming and organizing the
Corporation are hereby approved, ratified, and adopted as valid and
binding acts of the Company.
-9-
(b) Each officer of the Company
appointed by the Board of Managers pursuant to Section 5.04 is
hereby designated as an “authorized person,” within the
meaning of Section 18-201 of the Delaware Act, to execute,
deliver and file, or cause the execution, delivery and filing of,
all certificates, notices or other instruments (and any amendments
and/or restatements thereof) required or permitted by the Delaware
Act to be filed in the office of the Secretary of State of the
State of Delaware and any other certificates, notices or other
instruments (and any amendments or restatements thereof) necessary
for the Company to qualify to do business in a jurisdiction in
which the Company may wish to conduct business.
SECTION 2.02 Name
. The name of the Company shall be “Perseid Therapeutics
LLC”. Without the need to amend this Agreement, the Board of
Managers may change the name of the Company from time to time in
its sole discretion.
SECTION 2.03 Term
. The term of the Company commenced with the filing of the
Certificate of Formation in the office of the Secretary of State of
the State of Delaware, and shall continue perpetually unless the
Company is dissolved pursuant to Section 9.01.
SECTION 2.04 Registered
Agent and Registered Office . The Company’s
registered agent for service of process is The Corporation Trust
Company, and the address of the registered agent and the address of
the registered office of the Company in the State of Delaware shall
be The Corporation Trust Company, Corporation Trust Center, 1209
Orange Street, Wilmington, DE 19801. Such registered agent and such
registered office may be changed from time to time by the Board of
Managers.
SECTION 2.05 Principal Place
of Business . As of the date of this Agreement, the
principal place of business of the Company is located in Redwood
City, California. Thereafter, the principal place of business of
the Company shall be in such location as the Board of Managers may
designate from time to time.
SECTION 2.06 Purposes and
Powers . The Company is formed for the object and purpose
of, and the nature of the business to be conducted and promoted by
the Company is, engaging in any act or activity for which limited
liability companies may be formed under the Delaware Act. The
Company shall have the power and authority to take any and all
actions necessary, appropriate, proper, advisable, incidental or
convenient to or for the furtherance of the purposes set forth in
this Section 2.06.
SECTION 2.07 Books and
Records . At all times during the continuance of the
Company, the Company shall maintain or cause to be maintained
proper and complete books and records in which shall be entered
fully and accurately all transactions and other matters relating to
the Company’s business in the detail and completeness
customary and usual for businesses of the type engaged in by the
Company.
-10-
ARTICLE 3.
MEMBERS
SECTION 3.01 Members
.
(a) Upon the execution of this
Agreement, the sole Members of the Company shall be the Initial
Members. Following the execution of this Agreement, no Person shall
be admitted as a Member and no Units shall be issued by the Company
except as expressly provided in this Agreement.
(b) After the date of this
Agreement, a Person shall only be admitted as a Member (such
Person, an “ Additional Member ”) if such Person
is issued any Units in accordance with Section 4.02 or is a
valid assignee or transferee of any then outstanding Units in
accordance with the relevant provisions of the Investors’
Rights Agreement and the Co-Sale Agreement, as applicable. Nothing
in this Agreement shall require the consent or approval of any
Member for the admission of any Additional Member.
(c) The name and mailing address of
each Member and the number of Units held by such Member shall be
listed on Schedule A . An officer designated by the
Board of Managers pursuant to Section 5.04 shall update
Schedule A from time to time as necessary to accurately
reflect changes in the Units of any Member to reflect the
consummation of any action taken in accordance with this Agreement.
Any amendment or revision to Schedule A made to reflect
an action taken in accordance with this Agreement shall not be
deemed an amendment to this Agreement. Any reference in this
Agreement to Schedule A shall be deemed to be a
reference to Schedule A as amended and in effect from
time to time. The Company shall provide the Members with any
amendment or revision of Schedule A (including any
subsequent amendments or revisions thereto) within three
(3) days of such amendment or revision.
SECTION 3.02 Powers of
Members . Members shall not have the authority to transact
any business in the Company’s name or bind the Company by
virtue of their status as Members.
SECTION 3.03 Voting
Rights .
(a) The Members hereby delegate the
management of the Company to the Managers except with respect to
(i) the automatic conversion of the Preferred Units in
accordance with Section 4.03(b), (ii) the waiver of
adjustments to the Conversion Price in accordance with
Section 4.03(i), (iii) the shortening or waiver of
certain notice provisions pursuant to Section 4.03(j),
(iv) the designation and removal of Managers in accordance
with Section 5.01(b), (v) the approval of those matters
specified in Section 5.05 and Section 5.06, (vi) the
approval of certain matters in connection with a Liquidity Event in
accordance with Section 8.02, (vii) the dissolution of
the Company in accordance with Section 9.01 and
(viii) any amendment of this Agreement in accordance with
Section 10.09.
-11-
(b) Other than as provided herein,
the Members shall vote together as a single class on all matters on
which they are specifically entitled to vote pursuant to this
Agreement. Each Member holding Preferred Units shall be entitled to
the number of votes equal to the number of Common Units into which
such Preferred Units could be converted as of the record date.
Fractional votes shall not, however, be permitted and any
fractional voting rights resulting from the above formula (after
aggregating all Common Units into which Preferred Units held by
each Member could be converted), shall be disregarded.
(c) Notwithstanding anything in this
Agreement to the contrary, the Profits Interest Units shall be
non-voting and shall not entitle the holders of Profits Interest
Units, as such, to act for the Company or vote upon or approve any
matter submitted to the Members for approval.
SECTION 3.04 Meetings and
Written Consents of Members .
(a) The Company shall provide
written notice to all Members of any meeting at which a vote will
be held not less than ten (10) nor more than sixty
(60) calendar days at prior thereto, which notice shall
describe the business to be considered, the actions to be taken and
the matters to be voted on at the meeting in reasonable detail. At
any meeting of the Members, the presence, in person or by proxy, of
Members holding a majority of the votes which could be cast by the
holders of all Units entitled to vote at the meeting shall be
necessary and sufficient to constitute a quorum, subject in each
case to the provisions of Section 5.05 and Section 5.06.
Any action permitted or required to be taken by the Members may be
taken without a meeting, without prior notice and without a vote if
a consent or consents in writing, setting forth the action so
taken, shall be signed by the holders of Units having not less than
the minimum number of votes that would be necessary to authorize or
take such action at a meeting at which all Units entitled to vote
thereon were present and voted. Within five (5) calendar days
of taking of action by Members without a meeting by less than
unanimous written consent, the Company shall provide written notice
of the taking of such action to those Members who have not
consented in writing to the taking of such action, which notice
shall describe the actions taken in reasonable detail.
(b) In order that the Company may
determine the Members entitled to notice of or to vote at any
meeting of Members or any adjournment thereof, or entitled to
express consent to Company action in writing without a meeting, or
entitled to receive payment of any dividend or other Distribution
or allotment of any rights, or entitled to exercise any rights in
respect of any change, conversion or exchange of Units or for the
purpose of any other lawful action, the Board of Managers may fix a
record date, which record date shall not precede the date upon
which the resolution fixing the record date is adopted by the Board
of Managers and which record date:
(i) in the case of determination of
Members entitled to notice of or to vote at any meeting of Members
or adjournment thereof, shall, unless otherwise required by law,
not be more than sixty nor less than ten days before the date of
such meeting;
(ii) in the case of determination of
Members entitled to express consent to Company action in writing
without a meeting, shall not be more than ten (10) days after
the date upon which the resolution fixing the record date is
adopted by the Board of Managers; and
-12-
(iii) in the case of determination
of Members for any other action, shall not be more than sixty
(60) days prior to such other action.
If no record date is fixed by the
Board:
(i) the record date for determining
Members entitled to notice of or to vote at a meeting of Members
shall be at the close of business on the day next preceding the day
on which notice is given, or, if notice is waived, at the close of
business on the day next preceding the day on which the meeting is
held;
(ii) the record date for determining
Members entitled to express consent to Company action in writing
without a meeting when no prior action of the Board of Managers is
required by law, shall be the first date on which a signed written
consent setting forth the action taken or proposed to be taken is
delivered to the Company in accordance with applicable law, or, if
prior action by the Board of Managers is required by law, shall be
at the close of business on the day on which the Board of Managers
adopts the resolution taking such prior action; and
(iii) the record date for
determining Members for any other purpose shall be at the close of
business on the day on which the Board of Managers adopts the
resolution relating thereto.
A determination of Members of record
entitled to notice of or to vote at a meeting of Members shall
apply to any adjournment of the meeting, provided that the
Board of Managers may fix a new record date for the adjourned
meeting.
(c) Each Member entitled to vote at
a meeting of Members or to express consent or dissent to Company
action in writing without a meeting may authorize another Person or
Persons to act for such Member by proxy authorized by an instrument
in writing or by a transmission permitted by law filed in
accordance with the procedure established for the meeting, but no
such proxy shall be voted or acted upon after three (3) years
from its date, unless the proxy provides for a longer
period.
SECTION 3.05 Liability of
Members, Managers, Etc .
(a) Except to the extent provided in
the Delaware Act, none of the Members or any Manager shall have any
personal liability for the debts, obligations or liabilities of the
Company.
(b) To the fullest extent permitted
by applicable law (including Section 18-1101 of the Delaware
Act), notwithstanding any other provision of this Agreement or
otherwise of applicable law, including any in equity or at law, no
Member, Manager, officer or employee of the Company (collectively,
the “ Covered Persons ”), shall have any
fiduciary duty to the Company, the Members or the Managers (or any
other person or entity bound by this Agreement) by reason of this
Agreement or the Company or in its capacity as a Covered Person,
except that a Covered Person shall be subject to the implied
contractual covenant of good faith and fair dealing and (to the
extent expressly specified herein or therein) to the covenants and
express obligations set forth in this
-13-
Agreement and the Transaction Agreements. To the
fullest extent permitted by applicable law (including
Section 18-1101 of the Delaware Act), no Member or Manager
shall be liable, including under any legal or equitable theory of
fiduciary duty or other theory of liability, to the Company, any
Member, any Manager or any other person or entity bound by this
Agreement for any losses, claims, damages or liabilities incurred
by reason of any act or omission performed or omitted by such
Member or Manager in its capacity as a Member or Manager, except
that (i) a Member or Manager shall be liable for any act or
omission that constitutes a bad faith violation of the implied
contractual covenant of good faith and fair dealing and (ii) a
Member shall be liable for any breach by such Member of the
covenants and express obligations set forth in this Agreement or
the Transaction Agreements. The provisions of this Agreement, to
the extent that they restrict or eliminate the duties and
liabilities of a Member or Manager otherwise existing at law or in
equity, are agreed by the parties hereto to replace such other
duties and liabilities of such Member or Manager. Without
limitation to the foregoing, the Company renounces any interest,
right or expectancy of the Company in, or in being offered an
opportunity to participate in, or in being informed about, any
Excluded Opportunity. A Member or Manager shall be fully protected
in relying in good faith upon the records of the Company and upon
such information, opinions, reports or statements presented to the
Company by any Person as to matters which such Member or Manager
reasonably believes are within such Person’s professional or
expert competence.
(c) (i) Each Person who was or is
made a party or is threatened to be made a party to or is otherwise
involved in any action, suit or proceeding, whether civil,
criminal, administrative or investigative, by reason of the fact
that he is or was a Manager or officer of the Company or is or was
serving at the request of the Company as a Manager, officer,
employee or agent of another limited liability company or of a
corporation, partnership, joint venture, trust or other enterprise,
including service with respect to an employee benefit plan
(hereinafter an “ Indemnitee ”), whether the
basis of such proceeding is alleged action in an official capacity
as a Manager, officer, employee or agent or in any other capacity
while serving as a Manager, officer, employee or agent, shall be
indemnified and held harmless by the Company if the Indemnitee
acted in good faith and in a manner the Indemnitee reasonably
believed to be in or not opposed to the best interests of the
Company, and, with respect to any criminal action or proceeding,
had no reasonable cause to believe the Indemnitee’s conduct
was unlawful, against all expense, liability and loss (including
attorneys’ fees, judgments, fines, excise taxes under the
Employee Retirement and Income Security Act of 1974 or penalties
and amounts paid in settlement) reasonably incurred or suffered by
such Indemnitee in connection therewith; provided ,
however , that except as provided in Section 3.05(f)
with respect to proceedings to enforce rights to indemnification,
the Company shall indemnify any such Indemnitee in connection with
a proceeding (or part thereof) initiated by such Indemnitee only if
such proceeding (or part thereof) was authorized by the Board of
Managers. This Section 3.05(c)(i) shall not apply to any
action by or in the right of the Company.
(ii) The Company shall indemnify any
Indemnitee who was or is a party or is threatened to be made a
party to any threatened, pending or completed action or suit by or
in the right of the Company to procure a judgment in its favor by
reason of the fact that the Indemnitee is or was an Indemnitee,
against expenses (including attorneys’ fees) actually and
reasonably incurred by the Indemnitee in connection with the
defense or settlement of such action or suit if the
-14-
Indemnitee acted in good faith and in a manner
the Indemnitee reasonably believed to be in or not opposed to the
best interests of the Company, except that no indemnification shall
be made in respect of any claim, issue or matter as to which the
Indemnitee shall have been adjudged to be liable to the Company
unless and only to the extent that the Delaware Court of Chancery
or the court in which such action or suit was brought shall
determine upon application that, despite the adjudication of
liability but in view of all the circumstances of the case, such
Indemnitee is fairly and reasonably entitled to indemnity for such
expenses which the Delaware Court of Chancery or such other court
shall deem proper.
(d) To the extent that a present or
former Manager or officer of the Company has been successful on the
merits or otherwise in defense of any action, suit or proceeding
described in Section 3.05(c), or in defense of any claim,
issue or matter therein, such Indemnitee shall be indemnified
against expenses (including attorneys’ fees) actually and
reasonably incurred by such Indemnitee in connection
therewith.
(e) The Company shall pay the
expenses (including attorneys’ fees) incurred by a Manager in
defending any Proceeding in advance of its final disposition;
provided , however , that such payment of expenses
incurred by an Indemnitee shall be made only upon receipt of an
undertaking by such Manager to repay all amounts so advanced if it
should be ultimately determined that such Indemnitee is not
entitled to be indemnified under this Section 3.05(e) or
otherwise. Such expenses (including attorneys’ fees) incurred
by former Managers, officers or other employees and agents may be
so paid upon such terms and conditions, if any, as the Company
deems appropriate. The right to advancement of expenses shall not
apply where indemnity is excluded pursuant to this Agreement.
Notwithstanding the foregoing, unless otherwise determined pursuant
to Section 3.05(j), no advance shall be made by the Company to
an officer of the Company (except by reason of the fact that such
officer is or was a Manager of the Company, in which event this
sentence shall not apply) in any proceeding if a determination is
reasonably and promptly made (i) by a majority vote of the
Managers who are not parties to such proceeding, even though less
than a quorum, or (ii) by a committee of such Managers
designated by majority vote of such Managers, even though less than
a quorum, or (iii) if there are no such Managers, or if such
Managers so direct, by independent legal counsel in a written
opinion, that facts known to the decision-making party at the time
such determination is made demonstrate clearly and convincingly
that such person acted in bad faith or in a manner that such person
did not believe to be in or not opposed to the best interests of
the Company.
(f) Subject to the requirements in
this Section 3.05, the Company shall not be obligated to
indemnify any person in connection with any proceeding (or any part
of any proceeding):
(i) for which payment has actually
been made to or on behalf of such person under any statute,
insurance policy, indemnity provision, vote or otherwise, except
with respect to any excess beyond the amount paid;
-15-
(ii) for an accounting or
disgorgement of profits pursuant to Section 16(b) of the
Exchange Act, or similar provisions of federal, state or local
statutory law or common law, if such person is held liable therefor
(including pursuant to any settlement arrangements);
(iii) for any reimbursement of the
Company by such person of any bonus or other incentive-based or
equity-based compensation or of any profits realized by such person
from the sale of securities of the Company, as required in each
case under the Exchange Act, as amended (including any such
reimbursements that arise from an accounting restatement of the
Company pursuant to Section 304 of the Sarbanes-Oxley Act, or
the payment to the Company of profits arising from the purchase and
sale by such person of securities in violation of Section 306
of the Sarbanes-Oxley Act), if such person is held liable therefor
(including pursuant to any settlement arrangements);
(iv) initiated by such person,
including any proceeding (or any part of any proceeding) initiated
by such person against the Company or its directors, officers,
employees, agents or other indemnitees, unless (a) the Board
authorized the Proceeding (or the relevant part of the Proceeding)
prior to its initiation, (b) the Company provides the
indemnification, in its sole discretion, pursuant to the powers
vested in the Company under applicable law, (c) otherwise
required to be made under SECTION 3.05(g) or otherwise required by
applicable law; or
(v) if prohibited by applicable
law.
(g) If a claim under
Section 3.05(c) or Section 3.05(d) is not paid in full by
the Company within ninety (90) calendar days after a written
claim has been received by the Company, the Indemnitee may at any
time thereafter bring suit against the Company to recover the
unpaid amount of the claim. If successful in whole or in part in
any such suit, or in a suit brought by the Company to recover an
advancement of expenses pursuant to the terms of an undertaking,
the Indemnitee shall also be entitled to be paid the expenses of
prosecuting or defending such suit. In (i) any suit brought by
the Indemnitee to enforce a right to indemnification hereunder (but
not in a suit brought by the Indemnitee to enforce a right to an
advancement of expenses) it shall be a defense that, and
(ii) any suit brought by the Company to recover an advancement
of expenses pursuant to the terms of an undertaking, the Company
shall be entitled to recover such expenses upon a final
adjudication that, the Indemnitee has not met the applicable
standard for indemnification set forth in Section 3.05(c) and
Section 3.05(d). Neither the failure of the Company (including
its Board of Managers, independent legal counsel, or its Members)
to have made a determination prior to the commencement of such suit
that indemnification of the Indemnitee is proper in the
circumstances because the Indemnitee has met the standard of
conduct for entitlement to indemnification, nor an actual
determination by the Company (including its Board of Managers,
independent legal counsel, or its Members) that the Indemnitee has
not met the standard of conduct for entitlement to indemnification,
shall create a presumption that the Indemnitee has not met such
standard of conduct or, in the case of such a suit brought by the
Indemnitee, be a defense to such suit. In any suit brought by the
Indemnitee to enforce a right to indemnification or to an
advancement of expenses hereunder, or brought by the Company to
recover an advancement of expenses pursuant to the terms of an
undertaking, the burden of proving that the Indemnitee is
not
-16-
entitled to be indemnified, or to such
advancement of expenses, under this Section 3.05 or otherwise
shall be on the Company. The termination of a proceeding by
judgment, order, settlement, conviction, or upon a plea of nolo
contendere or its equivalent shall not of itself create a
presumption that a Manager or officer acted in such a manner as to
make him or her ineligible for indemnification.
(h) The rights to indemnification
and to the advancement of expenses conferred in this
Section 3.05 shall not be exclusive of any other right which
any Person may have or hereafter acquire under any statute, this
Agreement, any other agreement, any vote of Managers or
otherwise.
(i) The Company may maintain
insurance, at its expense, to protect itself and any Member,
Manager, officer, employee or agent of the Company or another
limited liability company, corporation, partnership, joint venture,
trust or other enterprise against any expense, liability or loss,
whether or not the Company would have the power to indemnify such
Person against such expense, liability or loss under the Delaware
Act.
(j) The Company may, to the extent
authorized from time to time by the Board of Managers, grant rights
to indemnification and to the advancement of expenses to any person
or entity not mandatorily entitled to indemnification under this
Section 3.05 and grant rights to indemnification and to the
advancement of expenses in addition to those granted in this
Section 3.05 to any person or entity mandatorily entitled to
indemnification under this Section 3.05, in each case as long
as such person or entity has met the standard of conduct set forth
in the first sentence of Section 3.05(b).
(k) The rights to indemnification
and advancement of expenses conferred by this Section 3.05
shall continue as to a person who has ceased to be a Manager,
officer, employee or agent and shall inure to the benefit of the
heirs, executors and administrators of such a person. Any
amendment, alteration or repeal of this Section 3.05 shall not
adversely affect any right or protection hereunder of any person in
respect of any act or omission occurring prior to such amendment,
alteration or repeal.
SECTION 3.06 Resignation .
Other than by transferring all of its Units, a Member may not
resign from the Company.
ARTICLE 4.
NEW ISSUANCES; UNITS;
CONVERSION
SECTION 4.01 New Issuances of
Equity Capital . Subject to the terms of this Agreement
(including Section 5.05 and Section 5.06), the Board of
Managers may determine the form, timing and terms of any new
issuance of equity capital (including Units) of the Company to any
Person and, other than with respect to issuances of Common Units to
eligible Persons pursuant to the terms of the Equity Incentive
Plan, will notify the Members of such decision. Any such Person
shall be required to become a party to this Agreement as a Member,
and shall have all the rights and obligations of a Member
hereunder, by executing an Adoption Agreement in form satisfactory
to the Board of Managers.
-17-
SECTION 4.02 Units
.
(a) Interests in the Company are
represented by one or more classes of Units. The Units shall for
all purposes be personal property in accordance with
Section 18-701 of the Delaware Act. No holder of a Unit or
Member shall have any interest in specific Company assets,
including any assets contributed to the Company by such Member as
part of any capital contribution. Each Member waives any and all
rights that it may have to maintain an action for partition of the
Company’s property.
(b) The Units initially will be
divided into Preferred Units and Common Units. The first series of
Preferred Units will be designated as Series A Preferred Units
and the second series of Preferred Units will be designated as
Series B Preferred Units. Each Unit shall have the rights and
privileges set forth in this Agreement.
(c) Subject to Section 5.05 and
Section 5.06, upon the issuance of any Common Units to
Managers, officers, employees or other service providers, the Board
of Managers may specify a “ Distribution Threshold
,” if any, applicable to such Common Units, which shall be
equal to the minimum amount determined by the Board of Managers in
its reasonable discretion to be necessary to cause such Common Unit
to constitute a “profits interest” for U.S. federal
income tax purposes (a “ Profits Interest Unit
”) or such greater amount as the Board of Managers, in its
reasonable discretion, may determine. All vested Profits Interest
Units shall terminate no later than the Option Closing (as such
term is defined in the Investors’ Rights Agreement), with the
unvested Profits Interest Units to terminate subsequently in
accordance with the Equity Incentive Plan, and in each case all
such terminated Profits Interest Units shall be exchanged for a
cash payment as provided for under the Investors’ Rights
Agreement and the Equity Incentive Plan. Immediately upon receipt
of a Profits Interest Unit, the recipient will have no initial
Capital Account balance and the Profits Interest Unit received
shall not entitle such Person to any portion of the capital of the
Company at the time of such Person’s admission to the Company
as a Member, such that if the Company’s assets were sold at
fair market value immediately after the grant to such Member of a
Profits Interest Unit and the proceeds distributed in complete
liquidation of the Company, the Profits Interest Unit so received
would entitle such Member to receive no share of those proceeds.
The grant of a Profits Interest Unit to a Member is intended to
comply with Rev. Proc. 93-27, 1993-2 C.B. 343 (1993) and Rev.
Proc. 2001-43, 2001-2 C.B. 191 (2001) and shall be interpreted
consistently therewith.
(d) Each Member authorizes the
Managing Member to elect to apply the safe harbor (the “
Safe Harbor ”) set forth in proposed Treasury
Regulation Section 1.83-3(l) and proposed IRS Revenue
Procedure published in Notice 2005-43 (together, the “
Proposed Treasury Regulation ”) (under which the fair
market value of an interest in an entity taxable as a partnership
that is transferred in connection with the performance of services
is treated as being equal to the liquidation value of the interest)
if such Proposed Treasury Regulation or a similar Treasury
Regulation is promulgated as a final or temporary Treasury
Regulation. If the Managing Member determines that
-18-
the Company should make such election, the
Managing Member is hereby authorized to amend this Agreement
without the consent of any Member or other Person to provide that
(i) the Company is authorized and directed to elect the Safe
Harbor, (ii) the Company and each Member (including any Person
to whom an Unit is transferred in connection with the performance
of services) will comply with all requirements of the Safe Harbor
with respect to all Units transferred in connection with the
performance of services while such election remains in effect and
(iii) the Company and each Member will take all actions
necessary, including providing the Company with any required
information, to permit the Company to comply with the requirements
set forth or referred to in the applicable Treasury Regulations for
such election to be effective such time (if any) as the Managing
Member determines, in his sole discretion, that the Company should
terminate such election. Notwithstanding anything to the contrary
in this Agreement, each Member expressly confirms and agrees that
it will be legally bound by any such amendment. Notwithstanding the
preceding sentences, no election or amendment shall be made
pursuant to this Section 4.02(d) if the Safe Harbor, when
finalized, is substantially different from the one included in the
Proposed Treasury Regulation, unless the Managing Member has
determined that the application of the Safe Harbor would not result
in materially adverse tax consequences to the Members.
(e) All Units other than the Profits
Interest Units shall be evidenced by certificat